ATE265861T1 - Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung - Google Patents

Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung

Info

Publication number
ATE265861T1
ATE265861T1 AT96928160T AT96928160T ATE265861T1 AT E265861 T1 ATE265861 T1 AT E265861T1 AT 96928160 T AT96928160 T AT 96928160T AT 96928160 T AT96928160 T AT 96928160T AT E265861 T1 ATE265861 T1 AT E265861T1
Authority
AT
Austria
Prior art keywords
selectin
antibodies against
prevent multiple
acute
organ failure
Prior art date
Application number
AT96928160T
Other languages
English (en)
Inventor
Anton Haselbeck
Guenther Schumacher
Man Sung Co
Ulrich Martin
Original Assignee
Protein Design Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protein Design Labs Inc filed Critical Protein Design Labs Inc
Application granted granted Critical
Publication of ATE265861T1 publication Critical patent/ATE265861T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
    • C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
AT96928160T 1995-08-17 1996-08-14 Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung ATE265861T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP95112895 1995-08-17
EP95114696 1995-09-19
US57895395A 1995-12-27 1995-12-27
PCT/US1996/013152 WO1997006822A1 (en) 1995-08-17 1996-08-14 Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage

Publications (1)

Publication Number Publication Date
ATE265861T1 true ATE265861T1 (de) 2004-05-15

Family

ID=27236574

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928160T ATE265861T1 (de) 1995-08-17 1996-08-14 Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung

Country Status (11)

Country Link
EP (1) EP0868197B1 (de)
JP (1) JP3604699B2 (de)
AT (1) ATE265861T1 (de)
AU (1) AU6773596A (de)
CA (1) CA2229140A1 (de)
CZ (1) CZ45498A3 (de)
DE (1) DE69632407T2 (de)
HU (1) HUP9901673A3 (de)
PL (1) PL187090B1 (de)
WO (1) WO1997006822A1 (de)
ZA (1) ZA966954B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6172213B1 (en) 1997-07-02 2001-01-09 Genentech, Inc. Anti-IgE antibodies and method of improving polypeptides
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
GB9919713D0 (en) 1999-08-19 1999-10-20 Queen Mary & Westfield College New medical use of high density lipoprotein
JP4473117B2 (ja) 2002-03-13 2010-06-02 バイオジェン・アイデック・エムエイ・インコーポレイテッド 抗αｖβ６抗体
CN104072614B (zh) * 2005-07-08 2017-04-26 生物基因Ma公司 抗-αvβ6 抗体及其用途
SG173364A1 (en) 2006-07-10 2011-08-29 Biogen Idec Inc Compositions and methods for inhibiting growth of smad4-deficient cancers
US10035859B2 (en) 2013-03-15 2018-07-31 Biogen Ma Inc. Anti-alpha V beta 6 antibodies and uses thereof
US10035860B2 (en) 2013-03-15 2018-07-31 Biogen Ma Inc. Anti-alpha V beta 6 antibodies and uses thereof
US20220249814A1 (en) 2018-11-19 2022-08-11 Progenity, Inc. Methods and devices for treating a disease with biotherapeutics
EP4309722A2 (de) 2019-12-13 2024-01-24 Biora Therapeutics, Inc. Einnehmbare vorrichtung zur abgabe eines therapeutischen mittels an den magen-darm-trakt

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2305192A (en) * 1991-06-25 1993-01-25 Dana-Farber Cancer Institute Monoclonal antibody to lymphocyte-associated cell surface protein
AU2410292A (en) * 1991-07-29 1993-03-02 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies to leukocyte adhesion molecule-1
CZ140195A3 (en) * 1992-12-01 1996-06-12 Protein Desing Labs Humanized antibodies reacting with l-selectin
AU2185195A (en) * 1993-11-30 1995-06-19 Protein Design Labs, Inc. Reperfusion therapy using antibodies to L-selectin

Also Published As

Publication number Publication date
PL187090B1 (pl) 2004-05-31
ZA966954B (en) 1998-02-16
EP0868197A1 (de) 1998-10-07
AU6773596A (en) 1997-03-12
JPH10510553A (ja) 1998-10-13
CZ45498A3 (cs) 1999-01-13
HUP9901673A2 (hu) 1999-08-30
WO1997006822A1 (en) 1997-02-27
EP0868197B1 (de) 2004-05-06
DE69632407D1 (de) 2004-06-09
DE69632407T2 (de) 2005-06-02
EP0868197A4 (de) 1998-11-18
HUP9901673A3 (en) 2001-06-28
PL325012A1 (en) 1998-07-06
CA2229140A1 (en) 1997-02-27
JP3604699B2 (ja) 2004-12-22

Similar Documents

Publication Publication Date Title
WO2001077951A8 (en) System and methods for group retirement plan administration
ES2195970T3 (es) L-ribavirina y usos de la misma.
ATE234091T1 (de) Thrombin inhibitoren
NO975557D0 (no) Immortalisering og dismortalisering av celler
NO971568L (no) Analoger av keratinocyttvekstfaktor
ATE265861T1 (de) Antikörper gegen l-selectin zur vorbeugung von multiplem organversagen und akuter organschädigung
DE69622413D1 (de) Zusammensetzbares spielgerät,insbesondere zur herstellung von rollbahnen
NO983530L (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
DE69625230T2 (de) Thrombininhibitoren
DE69616074T2 (de) Ara-c derivate
FI970330A (fi) Imidatsopyridiini-atsolidinonit
BR9609114A (pt) Composição inseticida de terra diatomácea
ES2134430T3 (es) Procedimiento de fluoracion.
BR9606955A (pt) Heterocicloalquenos substituísos
BR0012185A (pt) Sistema e método para comunicação entre várias aplicações de "strings" de endereço único
IT1278525B1 (it) Impianto di diffusione sonora,particolarmente per grandi ambienti
BR9611619B1 (pt) ciclopeptolìdeos e composição farmacêutica que os contêm.
DE69717147T2 (de) Thrombin inhibitoren
ATE240114T1 (de) Muramylpeptide zusammensetzungen für inhibierung von hiv replikation
ECSP961978A (es) 1- fenil- 2- dimetil-amino - metil ciclohexan ol, a procedimientos para su preparacion y la aplicación de estos compuestos en medicamentos
TW340240B (en) Multiple layer collector structure for bipolar transistors
ITRM950260A0 (it) Procedimento per la gestione centralizzata ed emissione di biglietti per spettacoli e/o manifestazioni organizzati da terzi e mezzi per la sua attuazione.
GR1001393B (el) Παράγωγα ιμιδαζο[2,1-Β] 3] βενζαζεπίνης, συν?έσεις και μέ?οδος χρήσεως.
RU95117476A (ru) Природный дубитель кожи
FR2712499B1 (fr) Ensemble laser-sonde endoscopique utile en microchirurgie.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties